Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage

NCT ID: NCT05220371

Last Updated: 2023-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-28

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims at investigating the potential influence of specific collagen peptides on recovery after exercise induced muscle damage with focus on long-term effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recovery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
Double-blind, randomized controlled trial

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Collagen

15g of collagen peptides ingested daily

Group Type EXPERIMENTAL

Collagen

Intervention Type DIETARY_SUPPLEMENT

Participants ingest 15 grams of either specific collagen peptides or Placebo daily

Concurrent training

Intervention Type OTHER

Both arms undergo a 12-week trainingintervention 3x/week

Placebo

15g of Placebo ingested daily

Group Type PLACEBO_COMPARATOR

Concurrent training

Intervention Type OTHER

Both arms undergo a 12-week trainingintervention 3x/week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Collagen

Participants ingest 15 grams of either specific collagen peptides or Placebo daily

Intervention Type DIETARY_SUPPLEMENT

Concurrent training

Both arms undergo a 12-week trainingintervention 3x/week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No subjective symptoms during physical exertion
* Stable weight and dietary behaviour
* Body Mass Index (BMI) between 18.5 and 24.9
* No extensive strength/endurance sports so far (less than 3 h/week)
* No complaints during strenuous physical activity

Exclusion Criteria

* Circumstances that impair/prevent sporting activity (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis etc.)
* Intolerance/aversion to animal protein
* Arterial hypertension (high blood pressure) (syst \> 200 mmHg and/or diast \> 105 mmHg) at rest
* Presence of insulin-dependent diabetes mellitus
* Liver and/or kidney disease that precludes a high protein load
* Collagen supplementation or regular intake of other dietary supplements in the last 6 months.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CRI Collagen Research Institute GmbH

UNKNOWN

Sponsor Role collaborator

University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel König

Univ.-Prof. Dr. med. Daniel König

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Koenig, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Vienna, Institute of Sport Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Vienna, Institute of Sport Science

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, Konig D. Reduction in systemic muscle stress markers after exercise-induced muscle damage following concurrent training and supplementation with specific collagen peptides - a randomized controlled trial. Front Nutr. 2024 Mar 25;11:1384112. doi: 10.3389/fnut.2024.1384112. eCollection 2024.

Reference Type DERIVED
PMID: 38590831 (View on PubMed)

Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, Konig D. Influence of specific collagen peptides and 12-week concurrent training on recovery-related biomechanical characteristics following exercise-induced muscle damage-A randomized controlled trial. Front Nutr. 2023 Nov 16;10:1266056. doi: 10.3389/fnut.2023.1266056. eCollection 2023.

Reference Type DERIVED
PMID: 38035363 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00765

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Creatine and Motor Skill Acquisition
NCT05201651 UNKNOWN EARLY_PHASE1
Nutritional Strategies After Muscle Strain Injuries
NCT04100161 ACTIVE_NOT_RECRUITING NA